カテゴリー： QYResearch, 世界

世界の便秘薬による過敏性腸症候群市場 2019年

【英語タイトル】Global Irritable Bowel Syndrome with Constipation Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X10087）・商品コード：DATA909X10087
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：103
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、便秘薬による過敏性腸症候群の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他に、用途別には、病院、診療所、その他にセグメント区分し、便秘薬による過敏性腸症候群の世界市場を分析しました。


・エグゼクティブ・サマリー
・便秘薬による過敏性腸症候群の世界市場概要
・便秘薬による過敏性腸症候群の製造コスト構成分析
・便秘薬による過敏性腸症候群の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・便秘薬による過敏性腸症候群の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・便秘薬による過敏性腸症候群のセグメント分析（種類別）
（ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他）
・便秘薬による過敏性腸症候群のセグメント分析（用途別）
（病院、診療所、その他）
・便秘薬による過敏性腸症候群の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Nestle、Abbot Laboratories、Synergy Pharmaceuticals、Sucampo Pharmaceuticals、Novartis、Astellas Pharmaceuticals、）
・便秘薬による過敏性腸症候群の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Irritable Bowel Syndrome with Constipation Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Irritable Bowel Syndrome with Constipation Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome with Constipation Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome with Constipation Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Irritable Bowel Syndrome with Constipation Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Nestle
Abbot Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis
Astellas Pharmaceuticals
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Lubiprostone
Linaclotide
Stimulant Laxatives
Osmotic Laxatives
Others

Segment by Application
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Irritable Bowel Syndrome with Constipation Drugs
1.1 Definition of Irritable Bowel Syndrome with Constipation Drugs
1.2 Irritable Bowel Syndrome with Constipation Drugs Segment by Type
1.2.1 Global Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Lubiprostone
1.2.3 Linaclotide
1.2.4 Stimulant Laxatives
1.2.5 Osmotic Laxatives
1.2.6 Others
1.3 Irritable Bowel Syndrome with Constipation Drugs Segment by Applications
1.3.1 Global Irritable Bowel Syndrome with Constipation Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Irritable Bowel Syndrome with Constipation Drugs Overall Market
1.4.1 Global Irritable Bowel Syndrome with Constipation Drugs Revenue (2014-2025)
1.4.2 Global Irritable Bowel Syndrome with Constipation Drugs Production (2014-2025)
1.4.3 North America Irritable Bowel Syndrome with Constipation Drugs Status and Prospect (2014-2025)
1.4.4 Europe Irritable Bowel Syndrome with Constipation Drugs Status and Prospect (2014-2025)
1.4.5 China Irritable Bowel Syndrome with Constipation Drugs Status and Prospect (2014-2025)
1.4.6 Japan Irritable Bowel Syndrome with Constipation Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Status and Prospect (2014-2025)
1.4.8 India Irritable Bowel Syndrome with Constipation Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Constipation Drugs
2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome with Constipation Drugs
2.4 Industry Chain Structure of Irritable Bowel Syndrome with Constipation Drugs

3 Development and Manufacturing Plants Analysis of Irritable Bowel Syndrome with Constipation Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Irritable Bowel Syndrome with Constipation Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Irritable Bowel Syndrome with Constipation Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Irritable Bowel Syndrome with Constipation Drugs Production and Capacity Analysis
4.2 Irritable Bowel Syndrome with Constipation Drugs Revenue Analysis
4.3 Irritable Bowel Syndrome with Constipation Drugs Price Analysis
4.4 Market Concentration Degree

5 Irritable Bowel Syndrome with Constipation Drugs Regional Market Analysis
5.1 Irritable Bowel Syndrome with Constipation Drugs Production by Regions
5.1.1 Global Irritable Bowel Syndrome with Constipation Drugs Production by Regions
5.1.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Regions
5.2 Irritable Bowel Syndrome with Constipation Drugs Consumption by Regions
5.3 North America Irritable Bowel Syndrome with Constipation Drugs Market Analysis
5.3.1 North America Irritable Bowel Syndrome with Constipation Drugs Production
5.3.2 North America Irritable Bowel Syndrome with Constipation Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Irritable Bowel Syndrome with Constipation Drugs Import and Export
5.4 Europe Irritable Bowel Syndrome with Constipation Drugs Market Analysis
5.4.1 Europe Irritable Bowel Syndrome with Constipation Drugs Production
5.4.2 Europe Irritable Bowel Syndrome with Constipation Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Irritable Bowel Syndrome with Constipation Drugs Import and Export
5.5 China Irritable Bowel Syndrome with Constipation Drugs Market Analysis
5.5.1 China Irritable Bowel Syndrome with Constipation Drugs Production
5.5.2 China Irritable Bowel Syndrome with Constipation Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Irritable Bowel Syndrome with Constipation Drugs Import and Export
5.6 Japan Irritable Bowel Syndrome with Constipation Drugs Market Analysis
5.6.1 Japan Irritable Bowel Syndrome with Constipation Drugs Production
5.6.2 Japan Irritable Bowel Syndrome with Constipation Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Irritable Bowel Syndrome with Constipation Drugs Import and Export
5.7 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Market Analysis
5.7.1 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Production
5.7.2 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Import and Export
5.8 India Irritable Bowel Syndrome with Constipation Drugs Market Analysis
5.8.1 India Irritable Bowel Syndrome with Constipation Drugs Production
5.8.2 India Irritable Bowel Syndrome with Constipation Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Irritable Bowel Syndrome with Constipation Drugs Import and Export

6 Irritable Bowel Syndrome with Constipation Drugs Segment Market Analysis (by Type)
6.1 Global Irritable Bowel Syndrome with Constipation Drugs Production by Type
6.2 Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Type
6.3 Irritable Bowel Syndrome with Constipation Drugs Price by Type

7 Irritable Bowel Syndrome with Constipation Drugs Segment Market Analysis (by Application)
7.1 Global Irritable Bowel Syndrome with Constipation Drugs Consumption by Application
7.2 Global Irritable Bowel Syndrome with Constipation Drugs Consumption Market Share by Application (2014-2019)

8 Irritable Bowel Syndrome with Constipation Drugs Major Manufacturers Analysis
8.1 Nestle
8.1.1 Nestle Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
8.1.2 Nestle Product Introduction, Application and Specification
8.1.3 Nestle Irritable Bowel Syndrome with Constipation Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Abbot Laboratories
8.2.1 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
8.2.2 Abbot Laboratories Product Introduction, Application and Specification
8.2.3 Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Synergy Pharmaceuticals
8.3.1 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
8.3.2 Synergy Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sucampo Pharmaceuticals
8.4.1 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
8.4.2 Sucampo Pharmaceuticals Product Introduction, Application and Specification
8.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Novartis
8.5.1 Novartis Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
8.5.2 Novartis Product Introduction, Application and Specification
8.5.3 Novartis Irritable Bowel Syndrome with Constipation Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Astellas Pharmaceuticals
8.6.1 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
8.6.2 Astellas Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Irritable Bowel Syndrome with Constipation Drugs Market
9.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Trend Analysis
9.1.1 Global Irritable Bowel Syndrome with Constipation Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Irritable Bowel Syndrome with Constipation Drugs Regional Market Trend
9.2.1 North America Irritable Bowel Syndrome with Constipation Drugs Forecast 2019-2025
9.2.2 Europe Irritable Bowel Syndrome with Constipation Drugs Forecast 2019-2025
9.2.3 China Irritable Bowel Syndrome with Constipation Drugs Forecast 2019-2025
9.2.4 Japan Irritable Bowel Syndrome with Constipation Drugs Forecast 2019-2025
9.2.5 Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Forecast 2019-2025
9.2.6 India Irritable Bowel Syndrome with Constipation Drugs Forecast 2019-2025
9.3 Irritable Bowel Syndrome with Constipation Drugs Market Trend (Product Type)
9.4 Irritable Bowel Syndrome with Constipation Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Irritable Bowel Syndrome with Constipation Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Irritable Bowel Syndrome with Constipation Drugs
Table Global Irritable Bowel Syndrome with Constipation Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Irritable Bowel Syndrome with Constipation Drugs Production Market Share by Types in 2018
Figure Lubiprostone Product Picture
Figure Linaclotide Product Picture
Figure Stimulant Laxatives Product Picture
Figure Osmotic Laxatives Product Picture
Figure Others Product Picture
Table Global Irritable Bowel Syndrome with Constipation Drugs Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Irritable Bowel Syndrome with Constipation Drugs Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Others
Figure Global Irritable Bowel Syndrome with Constipation Drugs Revenue (Million USD) (2014-2025)
Figure Global Irritable Bowel Syndrome with Constipation Drugs Production (K Units) (2014-2025)
Figure North America Irritable Bowel Syndrome with Constipation Drugs Market Size (Million USD) (2014-2025)
Figure Europe Irritable Bowel Syndrome with Constipation Drugs Market Size (Million USD) (2014-2025)
Figure China Irritable Bowel Syndrome with Constipation Drugs Market Size (Million USD) (2014-2025)
Figure Japan Irritable Bowel Syndrome with Constipation Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Market Size (Million USD) (2014-2025)
Figure India Irritable Bowel Syndrome with Constipation Drugs Market Size (Million USD) (2014-2025)
Table Irritable Bowel Syndrome with Constipation Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome with Constipation Drugs in 2018
Figure Manufacturing Process Analysis of Irritable Bowel Syndrome with Constipation Drugs
Figure Industry Chain Structure of Irritable Bowel Syndrome with Constipation Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Irritable Bowel Syndrome with Constipation Drugs Manufacturing Plants Distribution
Table Irritable Bowel Syndrome with Constipation Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Irritable Bowel Syndrome with Constipation Drugs Capacity (K Units) of Major Manufacturers (2014-2019)
Table Irritable Bowel Syndrome with Constipation Drugs Production (K Units) of Major Manufacturers (2014-2019)
Table Irritable Bowel Syndrome with Constipation Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Irritable Bowel Syndrome with Constipation Drugs Production Share by Manufacturers in 2018
Table Irritable Bowel Syndrome with Constipation Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Irritable Bowel Syndrome with Constipation Drugs Revenue Share by Manufacturers in 2018
Table Irritable Bowel Syndrome with Constipation Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Irritable Bowel Syndrome with Constipation Drugs Production by Regions 2014-2019 (K Units)
Table Global Irritable Bowel Syndrome with Constipation Drugs Production Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome with Constipation Drugs Production Market Share by Regions in 2018
Table Global Irritable Bowel Syndrome with Constipation Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Regions 2014-2019
Figure Global Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share by Regions in 2018
Table Global Irritable Bowel Syndrome with Constipation Drugs Consumption by Regions 2014-2019 (K Units)
Table Global Irritable Bowel Syndrome with Constipation Drugs Consumption Market Share by Regions 2014-2019
Figure North America Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate 2014-2019 (K Units)
Figure North America Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Irritable Bowel Syndrome with Constipation Drugs Production, Consumption Import and Export (K Units)
Figure Europe Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate 2014-2019 (K Units)
Figure Europe Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Irritable Bowel Syndrome with Constipation Drugs Production, Consumption Import and Export (K Units)
Figure China Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate 2014-2019 (K Units)
Figure China Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Irritable Bowel Syndrome with Constipation Drugs Production, Consumption Import and Export (K Units)
Figure Japan Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate 2014-2019 (K Units)
Figure Japan Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Irritable Bowel Syndrome with Constipation Drugs Production, Consumption Import and Export (K Units)
Figure Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Production, Consumption Import and Export (K Units)
Figure India Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate 2014-2019 (K Units)
Figure India Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Irritable Bowel Syndrome with Constipation Drugs Production, Consumption Import and Export (K Units)
Figure Global Consumption Irritable Bowel Syndrome with Constipation Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Irritable Bowel Syndrome with Constipation Drugs Market Share by Application (2014-2019)
Table Nestle Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
Table Nestle Irritable Bowel Syndrome with Constipation Drugs Product Introduction, Application and Specification
Table Nestle Irritable Bowel Syndrome with Constipation Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Nestle Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate (2014-2019)
Table Nestle Irritable Bowel Syndrome with Constipation Drugs Production Market Share (2014-2019)
Figure Nestle Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share (2014-2019)
Table Nestle Irritable Bowel Syndrome with Constipation Drugs Main Business and Markets Served
Table Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
Table Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Product Introduction, Application and Specification
Table Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate (2014-2019)
Table Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Production Market Share (2014-2019)
Figure Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share (2014-2019)
Table Abbot Laboratories Irritable Bowel Syndrome with Constipation Drugs Main Business and Markets Served
Table Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
Table Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Introduction, Application and Specification
Table Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate (2014-2019)
Table Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Market Share (2014-2019)
Figure Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share (2014-2019)
Table Synergy Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Main Business and Markets Served
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Introduction, Application and Specification
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate (2014-2019)
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Market Share (2014-2019)
Figure Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share (2014-2019)
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Main Business and Markets Served
Table Novartis Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
Table Novartis Irritable Bowel Syndrome with Constipation Drugs Product Introduction, Application and Specification
Table Novartis Irritable Bowel Syndrome with Constipation Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate (2014-2019)
Table Novartis Irritable Bowel Syndrome with Constipation Drugs Production Market Share (2014-2019)
Figure Novartis Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share (2014-2019)
Table Novartis Irritable Bowel Syndrome with Constipation Drugs Main Business and Markets Served
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Sites and Area Served
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Product Introduction, Application and Specification
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate (2014-2019)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Production Market Share (2014-2019)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Revenue Market Share (2014-2019)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome with Constipation Drugs Main Business and Markets Served
Figure Global Irritable Bowel Syndrome with Constipation Drugs Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Irritable Bowel Syndrome with Constipation Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Irritable Bowel Syndrome with Constipation Drugs Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Irritable Bowel Syndrome with Constipation Drugs Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Irritable Bowel Syndrome with Constipation Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Irritable Bowel Syndrome with Constipation Drugs by Type (2019-2025)
Table Global Consumption (K Units) of Irritable Bowel Syndrome with Constipation Drugs by Application (2019-2025)
Table Irritable Bowel Syndrome with Constipation Drugs Distributors List
Table Irritable Bowel Syndrome with Constipation Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Nestle、Abbot Laboratories、Synergy Pharmaceuticals、Sucampo Pharmaceuticals、Novartis、Astellas Pharmaceuticals、

★調査レポート[世界の便秘薬による過敏性腸症候群市場 2019年] (コード：DATA909X10087)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の便秘薬による過敏性腸症候群市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の下痢を伴う過敏性腸症候群（IBS-D）薬市場 2019年
    DATA909X10088 / QYResearch / 2019年11月20日 / ※本調査レポートは、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、序文、エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン及びヒヨスチアミンに、用途別には、病院、診療所、その他にセグメント区分し、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要 ・下痢を伴う過敏性腸症候群（IBS-D）薬の製造コスト構成分析 ・下痢を伴う過敏性腸症候群（IBS-D）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・下痢を伴う過敏性腸症候群（IBS-D）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・下痢を伴う過敏性腸症候群（IBS-D）薬のセグメント分析（種類別） （序文、エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン及びヒヨスチアミン）...The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in...
  • 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年
    DATA909X13285 / QYResearch / 2019年11月20日 / ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要 ・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析 ・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別） （経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）...The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のドライアイ症候群薬市場 2019年
    DATA909X06827 / QYResearch / 2019年11月15日 / ※本調査レポートは、ドライアイ症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗生物質ドロップ、ホルモンドロップ、人工涙液、その他に、用途別には、病院、診療所、家庭用、その他にセグメント区分し、ドライアイ症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ドライアイ症候群薬の世界市場概要 ・ドライアイ症候群薬の製造コスト構成分析 ・ドライアイ症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ドライアイ症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ドライアイ症候群薬のセグメント分析（種類別） （抗生物質ドロップ、ホルモンドロップ、人工涙液、その他）...The global Dry Eye Syndrome Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Dry Eye Syndrome Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dry Eye Syndrome Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Dry Eye Syndrome Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のギランバレー症候群薬市場 2019年
    DATA909X08653 / QYResearch / 2019年11月15日 / ※本調査レポートは、ギランバレー症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Coversin、免疫グロブリン、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ギランバレー症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ギランバレー症候群薬の世界市場概要 ・ギランバレー症候群薬の製造コスト構成分析 ・ギランバレー症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ギランバレー症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ギランバレー症候群薬のセグメント分析（種類別） （Coversin、免疫グロブリン、その他）...The global Guillain-Barre Syndrome Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Guillain-Barre Syndrome Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Guillain-Barre Syndrome Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Guillain-Barre Syndrome Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の炎症性腸疾患治療市場 2019年
    DATA909X09776 / QYResearch / 2019年11月20日 / ※本調査レポートは、炎症性腸疾患治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アミノサリチル酸塩、TNF阻害剤、コルチコステロイド、免疫調節剤に、用途別には、小売薬局、病院薬局、オンライン薬局にセグメント区分し、炎症性腸疾患治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・炎症性腸疾患治療の世界市場概要 ・炎症性腸疾患治療の製造コスト構成分析 ・炎症性腸疾患治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・炎症性腸疾患治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・炎症性腸疾患治療のセグメント分析（種類別） （アミノサリチル酸塩、TNF阻害剤、コルチコステロイド、免疫調節剤）...The global Inflammatory Bowel Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Inflammatory Bowel Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inflammatory Bowel Disease Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Inflammatory Bowel Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のトゥレット症候群薬市場 2019年
    DATA909X16695 / QYResearch / 2019年11月22日 / ※本調査レポートは、トゥレット症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AZD-5213、CPP-115、デューテトラベナジンER、エコピパム塩酸塩、その他に、用途別には、研究センター、病院、クリニック、その他にセグメント区分し、トゥレット症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・トゥレット症候群薬の世界市場概要 ・トゥレット症候群薬の製造コスト構成分析 ・トゥレット症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・トゥレット症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・トゥレット症候群薬のセグメント分析（種類別） （AZD-5213、CPP-115、デューテトラベナジンER、エコピパム塩酸塩、その他）...The global Tourette Syndrome Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tourette Syndrome Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tourette Syndrome Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tourette Syndrome Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆